Vivos Therapeutics, Inc. (NASDAQ:VVOS) Sees Large Decrease in Short Interest

Vivos Therapeutics, Inc. (NASDAQ:VVOS) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 249,000 shares, a decline of 27.6% from the February 28th total of 344,000 shares. Approximately 5.4% of the shares of the company are sold short. Based on an average daily trading volume, of 210,600 shares, the short-interest ratio is presently 1.2 days.

Vivos Therapeutics Trading Down 2.5 %

Shares of NASDAQ VVOS opened at $3.11 on Friday. The stock has a market cap of $18.32 million, a P/E ratio of -0.55 and a beta of 7.47. Vivos Therapeutics has a twelve month low of $1.91 and a twelve month high of $6.28. The stock has a 50 day moving average of $3.78 and a two-hundred day moving average of $3.60.

Hedge Funds Weigh In On Vivos Therapeutics

Institutional investors have recently modified their holdings of the business. Anson Funds Management LP purchased a new position in Vivos Therapeutics during the 4th quarter worth $1,041,000. Geode Capital Management LLC grew its holdings in shares of Vivos Therapeutics by 55.6% during the fourth quarter. Geode Capital Management LLC now owns 44,827 shares of the company’s stock worth $192,000 after buying an additional 16,025 shares during the last quarter. Cutter & CO Brokerage Inc. acquired a new position in Vivos Therapeutics in the 4th quarter valued at about $163,000. Finally, Commonwealth Equity Services LLC increased its position in Vivos Therapeutics by 23.8% in the 4th quarter. Commonwealth Equity Services LLC now owns 26,000 shares of the company’s stock valued at $112,000 after acquiring an additional 5,000 shares during the period. 26.35% of the stock is owned by institutional investors and hedge funds.

About Vivos Therapeutics

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.